About Fever Labs
Fever Labs is a private company based in New York, New York. It has reported $347,184,698 raised in six offerings on Form D since March 2015. Its chief executive is Ignacio Bachiller.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 11, 2023 | Jan 25, 2023 | $68,499,992of $70.0M target | 12 | $5.7M | EquityRule 506(b) | Form D ↗ |
| Dec 31, 2021 | Feb 10, 2022 | $220,878,504of $221.3M target | 29 | $7.6M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 21, 2019 | Jul 8, 2019 | $23,873,584of $30.0M target | 12 | $1.9M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 6, 2018 | Feb 20, 2018amended Jul 5, 2018 | $19,645,401of $21.3M target | 9 | $2.1M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 30, 2015 | Nov 16, 2015 | $6,036,314of $12.0M target | 5 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Mar 17, 2015 | Mar 30, 2015 | $8,250,903fully sold | 54 | $152K | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $347,184,698 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Fever Labs's Form D filed Jan 25, 2023.
Earlier filings also listed Michael Zeisser (director, last listed Feb 2022), Oskar Mielczarek de la Miel (director, last listed Jul 2019), Maria Cordon (director, last listed Jul 2019), Chen Moravsky (director, last listed Jul 2019), Jacob Bro Olesen (director, last listed Jul 2018), Hector Lopez Vilaseco (executive officer and director, last listed Jul 2018), Bernardo Hernandez (director, last listed Jul 2018) and Alejandro Zubillaga (director, last listed Jul 2018).